It’s unlikely that adding an antiplatelet agent to anticoagulation will increase the number of organ support-free days in critically ill patients with COVID-19, although it’s possible that survival in ...
The world’s largest trial of multiple interventions for critically ill adults with COVID-19 has simultaneously released results about two of its treatments, vitamin C and simvastatin LARKSPUR, Calif. ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “In our analysis of longer-term outcomes among ...
The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results ...
Clinical trials investigating use of two widely available products -- vitamin C and the statin drug simvastatin -- in critically ill COVID-19 patients have yielded far different results. Simvastatin ...
LOS ANGELES--(BUSINESS WIRE)--Global Coalition for Adaptive Research, the U.S. Sponsor of REMAP-COVID, announced that Eisai has ended the evaluation of eritoran in the REMAP-COVID study. Eritoran, an ...
The world’s largest trial of multiple interventions for critically ill adults with COVID-19 has simultaneously released results about two of its treatments, vitamin C and simvastatin Simvastatin, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback